At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Open, Randomized Comparative Trial of Two Different Schedules of Liposomal Amphotericin B Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections
In Brief
A Phase 2 clinical trial evaluating Voriconazole and Liposomal amphotericin B for Acute Myelogenous Leukemia and Myelodysplastic Syndrome. Completed, enrolled 120 participants across 1 site.
Detailed Summary
The goal of this clinical research study is to compare the effectiveness of liposomal amphotericin B given three times per week , versus liposomal amphotericin B given once per week, versus oral voriconazole in the prevention of fungal infections in patients with acute myeloid leukemia (AML) or myelodysplastic syndromes MDS who are receiving chemotherapy. The safety of these treatments will also be studied and compared.
Study Details
Timeline
Interventions
400 mg by mouth twice daily on day 1, followed by 200 mg by mouth twice daily
3 mg/kg intravenously three times per week over 2 hours +/- 15 minutes
9 mg/kg intravenously once per week over 2 hours +/- 15 minutes